Personal statement
Colin Suckling has been Freeland Professor of Chemistry at the University of Strathclyde since 1989. During the 1990s until 2002, he served successively as Dean of the Faculty of Science, Deputy Principal, and Vice Principal of the University of Strathclyde. Much of Professor Suckling's work during that time was strategic including the development of inter-institutional and interdisciplinary research partnerships notably the research collaboration with the University of Glasgow (WestCHEM), which was recognized publicly with the award of OBE in 2006.
Recent and current research interests focus on the synthesis and properties of heterocyclic compounds designed as molecular probes for biological systems or as drugs. Particular progress has been made in the field of fused pyrimidine compounds with anticancer and antiparasite activity and in the field of minor groove binders for DNA with antibacterial activity. Several discoveries are entering pre-clinical development.
Professor Suckling's standing in the field of heterocyclic chemistry has been recognized by the award of the Adrien Albert Lectureship of the Royal Society of Chemistry (2009-10) and his appointment as chairman of the 2011 International Congress of Heterocyclic Chemistry to be held in Glasgow.
Professional activities
- From blue sky research to big data- external perspectives on making knowledge work
- Speaker
- 6/2017
- There's no escape - single target, multiple effects
- Speaker
- 3/2015
- The antibacterial drug, MGB-BP-3, from discovery to clinical trial
- Speaker
- 2/2015
- Drug discovery backwards -from biological activity to target
- Speaker
- 7/2014
- Royal Society of Chemistry, North East Region
- Invited speaker
- 22/3/2011
- International Conference on Chemistry for Mankind: Innovative Ideas in Life Sciences. ICCM-2011
- Invited speaker
- 9/2/2011
More professional activities
Projects
- S-MGBs to Treat Invasive and Serious Fungal Diseases (IFDs)
- Scott, Fraser (Principal Investigator) Hunter, Iain (Co-investigator) Suckling, Colin (Co-investigator)
- 01-Jan-2022 - 30-Jan-2023
- Investigating a novel class of Gram-negative active antibiotic suitable for clinical use
- Scott, Fraser (Principal Investigator) Hunter, Iain (Co-investigator) Suckling, Colin (Co-investigator) Tucker, Nicholas (Co-investigator)
- 01-Jan-2020 - 30-Jan-2023
- Development of a first-in-class IKKalpha inhibitor for the treatment of castrate resistant p
- MacKay, Simon (Principal Investigator) Halbert, Gavin (Co-investigator) Paul, Andrew (Co-investigator) Suckling, Colin (Co-investigator) Watson, David (Co-investigator)
- 01-Jan-2020 - 30-Jan-2023
- Covid-19 Accelerated introduction of a novel class of resistance-proof antiviral drugs: Strathclyde Minor Groove Binders
- Scott, Fraser (Principal Investigator) Suckling, Colin (Co-investigator)
- 01-Jan-2020 - 30-Jan-2020
- Strathclyde COVID-19 Research Portfolio: Novel testing, digital health support and third sector collaboration for impact on social care
- Bedford, Tim (Principal Investigator) Corrigan, Damion (Co-investigator) Dunlop, Mark (Co-investigator) Egan, Kieren (Co-investigator) Fleming, Leanne (Co-investigator) Flowers, Paul (Co-investigator) Grealy, Madeleine (Co-investigator) Hoskisson, Paul (Co-investigator) Hunter, Iain (Co-investigator) Janssen, Xanne (Co-investigator) Kirk, Alison (Co-investigator) Knifton, Lee (Co-investigator) Lenhart, Otto (Co-investigator) Maguire, Roma (Co-investigator) Morton, Alec (Co-investigator) Quinn, Neil (Co-investigator) Scott, Fraser (Co-investigator) Suckling, Colin (Co-investigator) Ward, Andrew (Co-investigator) Williams, Lynn (Co-investigator)
- 01-Jan-2020 - 16-Jan-2021
- A new drug discovery pipeline for animal African trypanosomiasis / R150401-2
- Suckling, Colin (Principal Investigator) Burley, Glenn (Co-investigator)
- 01-Jan-2016 - 30-Jan-2019
More projects
Address
Pure and Applied Chemistry
Thomas Graham
Thomas Graham
Location Map
View
University of Strathclyde
in a larger map